Nichols Weston
Insider CIK 1746376 · NEUP 10% owner · CRNX Director · KRRO 10% owner · TCRX 10% owner · PASG 10% owner · CGEM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KRRO Korro Bio, Inc. | P Buy | 2026-10-26 | 2026-10-26 | 25,124 | $11.75 | $295.1K | 1,624,789 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-10-23 | 2026-10-26 | 2,510 | $12.11 | $30.4K | 1,599,665 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-10-22 | 2026-10-26 | 40,000 | $11.04 | $441.5K | 1,597,155 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-10-22 | 2026-10-26 | 12,175 | $9.68 | $117.8K | 1,557,155 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.76 | $772.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.77 | $772.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.77 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $66.71 | $1.17M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 16,300 | $85.00 | $1.39M | 5,925 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $66.71 | $1.17M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.77 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.77 | $772.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.76 | $772.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 16,300 | $85.00 | $1.39M | 5,925 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-08-10 | 2026-08-13 | 1,462 | $13.19 | $19.3K | 1,544,980 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-08-10 | 2026-08-13 | 1,462 | $13.19 | $19.3K | 1,544,980 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-08-06 | 2026-08-13 | 5,222 | $11.40 | $59.5K | 1,543,518 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-08-06 | 2026-08-13 | 5,222 | $11.40 | $59.5K | 1,543,518 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2026-06-25 | 2026-06-29 | 50,055 | $4.12 | $206.2K | 673,759 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-06-18 | 2026-06-22 | 9,730 | — | $0 | 9,730 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-06-18 | 2026-06-22 | 5,925 | — | $0 | 22,225 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-03-31 | 2026-04-02 | 520 | $10.60 | $5.5K | 1,538,296 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2025-12-23 | 2025-12-23 | 6,232 | $0.90 | $5.6K | 8,019,148 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2025-12-22 | 2025-12-23 | 75,500 | $0.90 | $68.0K | 8,012,916 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2025-12-19 | 2025-12-23 | 80,069 | $0.90 | $72.1K | 7,937,416 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | P Buy | 2025-10-28 | 2025-10-30 | 165,667 | $8.40 | $1.39M | 8,963,500 | SEC↗ |
| NEUP Neuphoria Therapeutics Inc | P Buy | 2025-10-21 | 2025-10-23 | 639,110 | $5.14 | $3.29M | 875,328 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | P Buy | 2025-10-17 | 2025-10-21 | 32,217 | $7.84 | $252.6K | 8,797,833 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | P Buy | 2025-10-16 | 2025-10-21 | 150,000 | $8.86 | $1.33M | 8,765,616 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | P Buy | 2025-10-15 | 2025-10-21 | 51,500 | $7.94 | $408.9K | 8,615,616 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | P Buy | 2025-10-14 | 2025-10-21 | 15,032 | $7.59 | $114.1K | 8,564,116 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | P Buy | 2025-10-10 | 2025-10-10 | 277,298 | $7.36 | $2.04M | 8,549,084 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | P Buy | 2025-10-09 | 2025-10-10 | 626,043 | $6.70 | $4.19M | 8,271,786 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | P Buy | 2025-10-08 | 2025-10-10 | 556,300 | $6.46 | $3.59M | 7,645,743 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2025-09-15 | 2025-09-15 | 11,900 | $6.99 | $83.2K | 623,704 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2025-09-12 | 2025-09-15 | 19,783 | $6.99 | $138.3K | 611,804 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2025-09-11 | 2025-09-15 | 325 | $6.96 | $2.3K | 592,021 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2025-07-24 | 2025-07-24 | 66,423 | $5.71 | $379.3K | 591,696 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2025-07-23 | 2025-07-24 | 49,302 | $5.74 | $283.0K | 525,273 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2025-07-22 | 2025-07-24 | 13,123 | $5.44 | $71.4K | 475,971 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-06-11 | 2025-06-13 | 10,350 | — | $0 | 10,350 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-06-11 | 2025-06-13 | 6,900 | — | $0 | 16,300 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2025-05-20 | 2025-05-21 | 1,200,000 | $1.20 | $1.44M | 7,946,141 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2025-05-19 | 2025-05-21 | 1,388,794 | $1.20 | $1.67M | 6,746,141 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2024-12-27 | 2024-12-31 | 373,645 | $0.65 | $242.9K | 9,256,953 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy deriv | 2024-12-26 | 2024-12-30 | 7,500,000 | $4.00 | $30.00M | 7,500,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2024-12-13 | 2024-12-16 | 100,000 | $2.90 | $290.0K | 5,357,347 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2024-12-12 | 2024-12-16 | 31,800 | $3.01 | $95.7K | 5,257,347 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2024-11-27 | 2024-11-27 | 29,300 | $0.67 | $19.6K | 8,883,308 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2024-11-26 | 2024-11-27 | 167,055 | $0.71 | $118.6K | 8,854,008 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2024-11-25 | 2024-11-27 | 259,998 | $0.56 | $145.6K | 8,686,953 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy | 2024-11-15 | 2024-11-19 | 947 | $4.34 | $4.1K | 5,225,547 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-06-07 | 2024-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-06-07 | 2024-06-11 | 3,400 | — | $0 | 9,400 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | P Buy deriv | 2024-04-19 | 2024-04-23 | 5,000,000 | $7.13 | $35.65M | 5,000,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-06-16 | 2023-06-21 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-06-16 | 2023-06-21 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | S Sale | 2023-05-31 | 2023-06-02 | 15,000 | $2.52 | $37.8K | 5,225,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | S Sale | 2023-05-31 | 2023-06-02 | 10,000 | $2.51 | $25.1K | 5,240,000 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | S Sale | 2023-05-31 | 2023-06-02 | 400 | $2.51 | $1.0K | 5,224,600 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-06-17 | 2022-06-21 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2021-06-22 | 2021-06-23 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2020-06-19 | 2020-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2019-06-21 | 2019-06-25 | 12,500 | — | $0 | 12,500 | SEC↗ |